Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of LRP2 agonists for generating myeloid-derived suppressor cells

Use of LRP2 agonists for generating myeloid-derived suppressor cells

US Patent 12146156 · Granted Nov 19, 2024

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Variant survivin vaccine for treatment of myeloma2025
Use of lactoferrin for generating myeloid-derived suppressor cells2025
Variant survivin vaccine for treatment of myeloma2021
Methods for monitoring polymorphonuclear myeloid derived suppressor cells2021
Double mutant survivin vaccine2019
Quinoline carboxamides for use in the treatment of multiple myeloma2019
Quinoline carboxamides for use in the treatment of multiple myeloma2018
P53 vaccines for the treatment of cancers2014